BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brooling J, Leal R. Secondary Sclerosing Cholangitis: a Review of Recent Literature. Curr Gastroenterol Rep 2017;19. [DOI: 10.1007/s11894-017-0583-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Kehl T, Biermann D, Briem-Richter A, Schoen G, Olfe J, Sachweh JS, Fischer L, Schaefer H, Kozlik-Feldmann R, Gottschalk U. Impact of hepatopathy in pediatric patients after surgery for complex congenital heart disease. PLoS One 2021;16:e0248776. [PMID: 33765046 DOI: 10.1371/journal.pone.0248776] [Reference Citation Analysis]
2 Di Giorgio A, Vergani D, Mieli-vergani G. Cutting edge issues in juvenile sclerosing cholangitis. Digestive and Liver Disease 2021. [DOI: 10.1016/j.dld.2021.06.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Talbot S, MacLaren V, Lafferty H. Sclerosing cholangitis in a patient treated with nivolumab. BMJ Case Rep 2021;14:e241700. [PMID: 34049893 DOI: 10.1136/bcr-2021-241700] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Fousekis FS, Theopistos VI, Mitselos IV, Skamnelos A, Kavvadias A, Katsanos KH, Christodoulou DK. Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. J Clin Med Res 2019;11:81-8. [PMID: 30700999 DOI: 10.14740/jocmr3680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
5 Tampe D, Korsten P, Bremer SCB, Winkler MS, Tampe B. Kinetics of Bilirubin and Ammonia Elimination during Hemadsorption Therapy in Secondary Sclerosing Cholangitis Following ECMO Therapy and Severe COVID-19. Biomedicines 2021;9:1841. [PMID: 34944657 DOI: 10.3390/biomedicines9121841] [Reference Citation Analysis]
6 Lin Y, Zhang J, Li X, Zheng D, Yu X, Liu Y, Lan F, Wang Z. Biallelic mutations in DCDC2 cause neonatal sclerosing cholangitis in a Chinese family. Clinics and Research in Hepatology and Gastroenterology 2020;44:e103-8. [DOI: 10.1016/j.clinre.2020.02.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zecher BF, Zenouzi R, Lang M, Karagiannis P, Clauditz T, Fischer L, Sterneck M, Schramm C, Lohse AW, Sebode M. [Severe secondary sclerosing cholangitis as manifestation of a very rare underlying disease]. Internist (Berl) 2021. [PMID: 34546401 DOI: 10.1007/s00108-021-01148-0] [Reference Citation Analysis]
8 Blesl A, Stadlbauer V. The Gut-Liver Axis in Cholestatic Liver Diseases. Nutrients 2021;13:1018. [PMID: 33801133 DOI: 10.3390/nu13031018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Martins P, Verdelho Machado M. Secondary Sclerosing Cholangitis in Critically Ill Patients: An Underdiagnosed Entity. GE Port J Gastroenterol 2020;27:103-14. [PMID: 32266307 DOI: 10.1159/000501405] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
10 Edwards K, Allison M, Ghuman S. Secondary sclerosing cholangitis in critically ill patients: a rare disease precipitated by severe SARS-CoV-2 infection. BMJ Case Rep 2020;13:e237984. [PMID: 33168538 DOI: 10.1136/bcr-2020-237984] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
11 Tan Z, Wang Q, Mao X, Zou R, Zhang J, Di Z, Wang H. Secondary sclerosing cholangitis from percutaneous transhepatic biliary drainage in a patient with gallbladder cancer after surgery: A case report. J Interv Med 2020;3:58-9. [PMID: 34805909 DOI: 10.1016/j.jimed.2020.01.010] [Reference Citation Analysis]
12 Zhang Z, Xu L, Qin N, Zhang J, Xiang Q, Liu Q, Cheng Y, Bai Y, Liu Q, Liu Y, Duan X, Cui Y. Case report: Secondary sclerosing cholangitis induced by lapatinib and vinorelbine in a metastasis breast cancer patient. Thorac Cancer 2021;12:1912-6. [PMID: 33957015 DOI: 10.1111/1759-7714.13986] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Yesilbas O, Sevketoglu E, Petmezci MT, Kihtir HS, Benzer M, Arikan C, Berdeli A, Baloglu H, Baskan O. Infant onset severe complement-mediated hemolytic uremic syndrome complicated by secondary sclerosing cholangitis. J Clin Apher 2018;33:619-23. [PMID: 30168181 DOI: 10.1002/jca.21651] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Kim HJ, Park MS, Son JW, Han K, Lee JH, Kim JK, Paik HC. Radiological patterns of secondary sclerosing cholangitis in patients after lung transplantation. Abdom Radiol (NY) 2019;44:1361-6. [PMID: 30377725 DOI: 10.1007/s00261-018-1819-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Koya Y, Shibata M, Shinohara N, Nebuya S, Oe S, Honma Y, Senju M, Sato N, Harada M. Secondary sclerosing cholangitis with hemobilia induced by pembrolizumab: Case report and review of published work. Hepatol Res. 2019;49:950-956. [PMID: 30861263 DOI: 10.1111/hepr.13329] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
16 Braun DS, Bushe B, Kedia P, Tarnasky P. Diagnosis of Secondary Sclerosing Cholangitis by Port Site Metastasis. Cureus 2021;13:e18177. [PMID: 34707953 DOI: 10.7759/cureus.18177] [Reference Citation Analysis]